Navigation Links
Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation
Date:5/12/2008

- Intercell AG ('Intercell') to acquire Iomai Corporation ('Iomai') in a fully recommended share/cash transaction for USD 6.60 per share of Iomai's

common stock representing a fully diluted equity value of Iomai of

approximately USD 189 million (EUR 122 million). Acquisition to be accomplished through stock-for-stock exchange for approximately 41 percent

of Iomai's current shares outstanding held by major shareholders for approximately 1.7 million Intercell shares (representing approximately four percent of Intercell's total outstanding shares), and an all-cash merger for the remaining fully diluted outstanding shares of Iomai's common stock

for approximately USD 119 million (EUR 77 million). - The deal creates a leading Traveler's Vaccine portfolio by combining

Intercell's Japanese Encephalitis vaccine with Iomai's needle-free Travelers' Diarrhea vaccine. The Travelers' Diarrhea vaccine is planned to enter pivotal Phase III trials in the first half of 2009 and is based on the only advanced needle-free vaccine patch technology in the industry.

Through the transaction Intercell gains access to a further product

generating technology platform. - Valuable expansion of Intercell's pipeline and leveraging Intercell's late stage product development and industrialization expertise with two further programs in clinical development including a vaccine patch for

pandemic influenza in Phase II.

- Intercell will finance the cash component of the transaction consideration of approximately USD 119 million (EUR 77 million) comfortably from existing reserves and expects to maintain profitability in 2008.

VIENNA, Austria and GAITHERSBURG, Md., May 12 /PRNewswire-FirstCall/ -- Intercell AG (VSE: ICLL) and Iomai Corporation (Nasdaq:

SOURCE Iomai Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
2. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
3. Image Solutions, Inc. Acquires Zurich Biostatistics, Inc.
4. New Data Show Doripenem as Effective as Commonly Used Therapies in Treating Hospital-Acquired Pneumonias
5. U.S. Preventive Medicine Acquires Specialty Disease Management
6. MacroChem Acquires Rights to Pexiganan, a Novel Topical Anti-Infective for Treatment of Diabetic Foot Infections, From Genaera
7. FDA Accepts Wyeths Supplemental New Drug Application for Tygacil for the Treatment of Patients with Community-Acquired Pneumonia
8. Nastech Reacquires Teriparatide (Parathyroid Hormone; PTH1-34) Nasal Spray from Procter & Gamble
9. Prescient Medical, Inc. Acquires New Technology to Detect Inflammation in Coronary Blood Vessels
10. Enanta Reports New Macrolide-Related Drug Class, Bicyclolides, to Combat Hospital and Community Acquired Superbug Infections, Including MRSA
11. Iomai Trial Shows 100 Percent Immune Response in Elderly Subjects Vaccinated With Novel Travelers Diarrhea Patch Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2014)... , Dec. 12, 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/ms3j8c/cardiac ) has announced the addition ... and Forecasts, 2012-2018"  report to their offering. Global ... 2016. The North America accounts ... Europe claims approximately 25% (2018). ...
(Date:12/15/2014)... , Dec. 15, 2014  Inovio Pharmaceuticals, ... it has been added to the NASDAQ Biotechnology ... Index will become effective upon market open on ... Index is designed to track the performance of ... as either biotechnology or pharmaceutical according to the ...
(Date:12/15/2014)... 2014 Investor-Edge has initiated coverage on ... Eli Lilly and Company (NYSE: LLY ), Nektar ... SNY ), and Novartis AG (NYSE: NVS ). ... http://investor-edge.com/register . On Friday, December 12, 2014, ... Jones Industrial Average lost 1.79%, to finish the day at ...
Breaking Medicine Technology:Cardiac Guidewires - Global Trends, Estimates and Forecasts, 2012-2018 2Cardiac Guidewires - Global Trends, Estimates and Forecasts, 2012-2018 3Cardiac Guidewires - Global Trends, Estimates and Forecasts, 2012-2018 4Inovio Pharmaceuticals Added to NASDAQ Biotechnology Index 2Inovio Pharmaceuticals Added to NASDAQ Biotechnology Index 3Inovio Pharmaceuticals Added to NASDAQ Biotechnology Index 4Analysts View on Pharma Equities - Zogenix, Eli Lilly, Nektar Therapeutics, Sanofi, and Novartis 2Analysts View on Pharma Equities - Zogenix, Eli Lilly, Nektar Therapeutics, Sanofi, and Novartis 3Analysts View on Pharma Equities - Zogenix, Eli Lilly, Nektar Therapeutics, Sanofi, and Novartis 4Analysts View on Pharma Equities - Zogenix, Eli Lilly, Nektar Therapeutics, Sanofi, and Novartis 5
... That Include Important Clues,Toward the Development of Customized ... New findings from,research supported by NARSAD, the world,s ... by Harvard-affiliated scientists are,providing important clues into how ... and perception -- the behaviors associated with many,psychiatric ...
... old with diffuse,pontine glioma compared to older children suggests ... in young patients, MEMPHIS, Tenn., May 29 ... under 3 years old,who have a brain tumor called ... than older children with the same cancer., Results ...
Cached Medicine Technology:NARSAD Researchers Identify Specific Genes and Family Traits Linked to Schizophrenia, Bipolar Disorder and Depression 2NARSAD Researchers Identify Specific Genes and Family Traits Linked to Schizophrenia, Bipolar Disorder and Depression 3NARSAD Researchers Identify Specific Genes and Family Traits Linked to Schizophrenia, Bipolar Disorder and Depression 4NARSAD Researchers Identify Specific Genes and Family Traits Linked to Schizophrenia, Bipolar Disorder and Depression 5NARSAD Researchers Identify Specific Genes and Family Traits Linked to Schizophrenia, Bipolar Disorder and Depression 6St. Jude Finds Young Age May Give Survival Advantage to Children With Certain Brain Tumors 2St. Jude Finds Young Age May Give Survival Advantage to Children With Certain Brain Tumors 3
(Date:12/19/2014)... HealthDay Reporter THURSDAY, Dec. 18, 2014 (HealthDay ... high levels of air pollution late in pregnancy may have ... Researchers found that of nearly 1,800 U.S. women who ... most air pollution during pregnancy were twice as likely to ... the third trimester, specifically, showed the strongest correlation to autism ...
(Date:12/19/2014)... News) -- Traveling through the same U.S. airport gate, ... others within a four-hour time span, illustrating just how ... "The exposures in this report were not prolonged ... terminal, highlighting the fact that measles is highly contagious," ... disease specialist at the U.S. Centers for Disease Control ...
(Date:12/19/2014)... By Steven Reinberg ... -- If you can,t balance on one leg for at ... stroke, Japanese researchers suggest. Difficulty standing on one leg ... occurred, which means the risk for more serious strokes is ... Stroke . "Individuals showing instability while standing on ...
(Date:12/17/2014)... Dr. Myo Nwe is the co-author of ... the Futureā€ and co-founder of the Ace Medical Weight Loss ... takes a broad look at the industry of weight loss, ... scrutiny. On film and in television shows, however, she says ... social aspects and played for basic laughs, which she believes ...
(Date:12/17/2014)... 2014 This prestigious award is ... have made outstanding and innovative contributions to the ... of private practice physical therapy by the Private ... , On behalf of Performance Physical Therapy, Michelle ... of Performance accepted the award at the Private ...
Breaking Medicine News(10 mins):Health News:Smog Exposure During Pregnancy Linked to Autism Risk 2Health News:Smog Exposure During Pregnancy Linked to Autism Risk 3Health News:Arriving Now at Gate 42: Measles 2Health News:Arriving Now at Gate 42: Measles 3Health News:Can You Balance on One Leg? You May Have Lower Stroke Risk 2Health News:Obesity Should Not Be a Hollywood Punchline, Weight Loss Doc Says 2Health News:Performance Physical Therapy Awarded with Jayne L. Snyder Private Practice of the Year 2014 2
... cue to safety; group seeks legislative help , , MONDAY, ... silent, hybrid cars pose a serious threat of injury and ... Council of the Blind, which is pushing the auto industry ... , "Traditionally, people who are blind or visually impaired learn ...
... (Nasdaq:,ICAD), an industry-leading provider of Computer-Aided Detection (CAD),solutions, ... to purchase the principal assets of CAD Sciences, ... NY. The,purchase price was $5 million, comprised of ... common stock. The number of shares issued was,calculated ...
... and Weight Management ... ... in applying advanced technology to emulate a health coaching,session via the ... and medication adherence, is launching HealthMedia(R),Overcoming(TM) Binge Eating. This revolutionary new ...
... Fidelity National,Financial, Inc. (NYSE: FNF ), ... management services and information services,today announced the opening ... Title de Mexico S.A. de C.V. ("Fidelity Title ... Vice President and General,Manager and Gerardo Martinez has ...
... July 21 Mylan Inc. (NYSE: MYL ... as vice president -,Investor Relations and as a ... Chief Financial Officer Edward J. Borkowski, Crookshank is,responsible ... for the,development and direction of activities that proactively ...
... and OTTAWA, July 21 iNutrition, Inc, ... ) subsidiaries of Natural Nutrition, Inc, (OTC,Bulletin ... have inked an,agreement with actor John O,Hurley ... be celebrity endorser and spokesman for the ...
Cached Medicine News:Health News:Hybrid Cars Pose Risk to Blind, Visually Impaired 2Health News:iCAD Completes Acquisition of CAD Sciences 2Health News:HealthMedia Launches First-Ever Binge Eating Campaign and Intervention to Take on Nation's Top Eating Disorder 2Health News:HealthMedia Launches First-Ever Binge Eating Campaign and Intervention to Take on Nation's Top Eating Disorder 3Health News:HealthMedia Launches First-Ever Binge Eating Campaign and Intervention to Take on Nation's Top Eating Disorder 4Health News:Fidelity National Financial, Inc. Announces Opening of Fidelity National Title de Mexico S.A. de C.V. 2Health News:Fidelity National Financial, Inc. Announces Opening of Fidelity National Title de Mexico S.A. de C.V. 3Health News:Daniel E. Crookshank Joins Mylan as Vice President - Investor Relations 2Health News:iNutrition Signs John O'Hurley to Launch New Internet Video Campaign 2
The Emit 2000 Phenytoin Assay is a homogeneous enzyme immunoassay intended for use in the quantitative analysis of phenytoin in human serum or plasma. Emit 2000 assays are designed for use with most ...
The Emit 2000 Phenytoin Assay is a homogeneous enzyme immunoassay for use in the quantitative analysis of phenytoin in human serum or plasma. Kits are conveniently packaged in Olympus Reagent Cartrid...
Our high quality therapeutic drug monitoring reagents, calibrators and controls are available for most chemistry analyzers. Reproducible and accurate results for your laboratory needs....
... The Emit 2000 Digoxin Assay ... intended for use in the ... human serum or plasma. Kits ... on the Roche COBAS MIRA, ...
Medicine Products: